Modeling Human Digestive Diseases With CRISPR-Cas9–Modified Organoids
Publication date
2019-02-01
Authors
Fujii, Masayuki
Clevers, Hans
Sato, Toshiro
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Insights into the stem cell niche have allowed researchers to cultivate adult tissue stem cells as organoids that display structural and phenotypic features of healthy and diseased epithelial tissues. Organoids derived from patients’ tissues are used as models of disease and to test drugs. CRISPR-Cas9 technology can be used to genetically engineer organoids for studies of monogenic diseases and cancer. We review the derivation of organoids from human gastrointestinal tissues and how CRISPR-Cas9 technology can be used to study these organoids. We discuss burgeoning technologies that are broadening our understanding of diseases of the digestive system.
Keywords
Colorectal Cancer, Gastric Cancer, Inflammatory Bowel Disease, Pancreatic Cancer, Taverne, Hepatology, Gastroenterology
Citation
Fujii, M, Clevers, H & Sato, T 2019, 'Modeling Human Digestive Diseases With CRISPR-Cas9–Modified Organoids', Gastroenterology, vol. 156, no. 3, pp. 562-576. https://doi.org/10.1053/j.gastro.2018.11.048